retatrutide type 2 diabetes trial nct

retatrutide type 2 diabetes trial nct Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 conducted in the USA Once-Monthly Incretin-, Amylin-, and THRβ-Targeting

Name: retatrutide type 2 diabetes trial nct Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 conducted in the USA Once-Monthly Incretin-, Amylin-, and THRβ-Targeting
Brand: ducotech.in
SKU: 70104010388
Price: 20.88 USD
Availability: InStock
Rating: 4.2241 (23 reviews)

SKU: 70104010388

4.2

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 7 - Aug 12

Description

Evidence and Guidance Allulose, a rare low-calorie sugar, has attracted interest for its potential metabolic benefits, particularly amongst individuals managing diabetes or taking glucagon-like peptide-1 (GLP-1) receptor agonist medications

We screen for G6PD deficiency, kidney issues, and other contraindications before treatment